The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,938,774 in first-year total cost, median $2,425,282.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-Q (O2)]2
- Special Emphasis Panel[ZDK1 GRB-6 (M2)]1
- Special Emphasis Panel[ZDK1 GRB-Q (J2)]1
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- CONNECTICUT CHILDREN'S MEDICAL CENTER1
- NORTHWESTERN UNIVERSITY AT CHICAGO1
- UNIVERSITY OF PENNSYLVANIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Utility of Random Biopsies in Inflammatory Bowel Disease1U01DK138901-01 | KAESTNER, KLAUS HLEWIS, JAMES D | UNIVERSITY OF PENNSYLVANIA, PA | $2,410,980 | ZDK1 |
| 2023 | Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease1U01DK134356-01 | DENSON, LEE ARMISTEADHYAMS, JEFFREY SAMUELKUGATHASAN, SUBRA | CONNECTICUT CHILDREN'S MEDICAL CENTER, CT | $2,799,999 | ZDK1 |
| 2023 | Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial1U01DK134321-01 | BONNER, LAUREN BALMERTDULAI, PARAMBIR SINGH | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $2,439,584 | ZDK1 |
| 2023 | Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial1U01DK136523-01 | LEBWOHL, BENJAMINWOLF, RANDI L. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $1,288,211 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.